Twenty-eight months progression-free survival after pyrotinib therapy for HER2-positive recurrent ovarian clear cell carcinoma: a case report

BACKGROUND: Ovarian cancer (OC) is the seventh most common newly diagnosed cancer in women worldwide. Ovarian clear cell carcinoma (OCCC) is a specific type of epithelial ovarian cancer with a poor prognosis. It has been revealed that human epidermal growth factor receptor 2 (HER2)-positive (2+/3+)...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jing, You, Yang, Zhuang, Rongyuan, Guo, Xi, Zhang, Chenlu, Zhang, Qi, Zhou, Yuhong, Li, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011316/
https://www.ncbi.nlm.nih.gov/pubmed/35433993
http://dx.doi.org/10.21037/atm-22-1045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011316/
https://www.ncbi.nlm.nih.gov/pubmed/35433993
http://dx.doi.org/10.21037/atm-22-1045

Ejemplares similares